Miwa Kawanaka

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma

Kohichiroh Yasui, Etsuko Hashimoto, Yasuji Komorizono et al. · Clinical Gastroenterology and Hepatology · 2011 · 418 citations

Medicine, Oncology, Pathology +17

Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese

Takahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura et al. · PLoS ONE · 2012 · 265 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD

Hirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka et al. · Hepatology Communications · 2021 · 149 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

Takahisa Kawaguchi, Toshihide Shima, Masayuki Mizuno et al. · PLoS ONE · 2018 · 146 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17